Dabigatran or rivaroxaban for nonvalvular atrial fibrillation?

Dean Seehusen, Nicolas Rathjen

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)E15
JournalEvidence-Based Practice
Volume20
Issue number12
StatePublished - Dec 1 2017
Externally publishedYes

Fingerprint

Atrial Fibrillation
Rivaroxaban
Dabigatran

ASJC Scopus subject areas

  • Fundamentals and skills

Cite this

Dabigatran or rivaroxaban for nonvalvular atrial fibrillation? / Seehusen, Dean; Rathjen, Nicolas.

In: Evidence-Based Practice, Vol. 20, No. 12, 01.12.2017, p. E15.

Research output: Contribution to journalComment/debate

@article{567532b826a146609617d6fe15965e65,
title = "Dabigatran or rivaroxaban for nonvalvular atrial fibrillation?",
author = "Dean Seehusen and Nicolas Rathjen",
year = "2017",
month = "12",
day = "1",
language = "English (US)",
volume = "20",
pages = "E15",
journal = "Evidence-Based Practice",
issn = "1095-4120",
publisher = "Dowden Health Media,Inc",
number = "12",

}

TY - JOUR

T1 - Dabigatran or rivaroxaban for nonvalvular atrial fibrillation?

AU - Seehusen, Dean

AU - Rathjen, Nicolas

PY - 2017/12/1

Y1 - 2017/12/1

UR - http://www.scopus.com/inward/record.url?scp=85050765213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050765213&partnerID=8YFLogxK

M3 - Comment/debate

VL - 20

SP - E15

JO - Evidence-Based Practice

JF - Evidence-Based Practice

SN - 1095-4120

IS - 12

ER -